Form 8-K · Current report
Keurig Dr Pepper 8-K, filed Nov 3, 2026
- Filed
- CIK
- 0001418135
- Accession no.
- 0001418135-26-000064
Summary
Keurig Dr Pepper reported third-quarter 2026 net sales of $7.34 billion, up 70.6% year over year, and adjusted diluted EPS of $0.66, up 22.2%, and reaffirmed its 2026 guidance of $25.9–$26.4 billion in net sales and low-double-digit constant-currency adjusted diluted EPS growth. The results include the JDE Peet's acquisition, which closed April 1 and added $2.6 billion in quarterly net sales, while the company's 2026 outlook now reflects revised expectations for U.S. Coffee.
Key points
- Q3 net sales rose 70.6% to $7.34 billion and adjusted diluted EPS rose 22.2% to $0.66; GAAP diluted EPS was $0.59.
- Excluding the JDE Peet's acquisition, legacy KDP net sales increased 8.6%, with volume/mix growth of 6.5%.
- The JDE Peet's acquisition closed on April 1 and contributed $2.6 billion of net sales in the quarter.
- CEO Tim Cofer said the company is on track to meet its 2026 commitments and remains focused on remaining milestones for its planned separation into two companies.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing. On November 3, 2026, Keurig Dr Pepper Inc. (the "Company" or "KDP") issued a press release announcing the Company's financial results for the third quarter of 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.